Hospital Utilization Rates for Oncology Patients in an Integrated Health System Compared to a National Networkhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster highlights how HSSP oncology patients had lower hospital utilization rates compared to a national network, indicating the potential for avoidable medical events. Implementing an integrated care model with…
Impact of an Ambulatory Clinical Pharmacist on Oral Oncolytics in a Hematology/Oncology Specialty Clinic Integrated with a Health System Specialty Pharmacyhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster highlights the positive impact of introducing ACP services into a hematology/oncology clinic, leading to successful outcomes and substantial cost savings following HSSP integration. Challenges in cost estimation stemmed…
Hospital Utilization Rates for Oncology Patients in an Integrated Health System Compared to a National Networkhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This research poster examines how HSSP oncology patients had lower hospital utilization rates compared to a national network, indicating potential benefits of an integrated care model with close clinical monitoring…
Raising Awareness For Breast Cancerhttps://shieldshealthsolutions.com/content/uploads/2022/10/Shutterstock_2192448741-1024x683.png1024683Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
As a Clinical pharmacist for Shields Health Solutions, I have had the privilege to focus on providing the best care for patients on specialty medications. With our care model, I…
Factors Influencing CDK4/6 Inhibitor Adherencehttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster highlights the analysis on CDK4/6 inhibitor patients at HSSPs showed strong and consistent adherence across drug, age group, insurance type, and location, highlighting the impact of the HSSP…
Pharmacist Impact on Coverage Outcomes in Oncologyhttps://shieldshealthsolutions.com/content/uploads/2023/05/web-resources-icon-posters.png216115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This poster examines how remote placement of an ambulatory clinical pharmacist alongside a pharmacy liaison improved approval rates for specialty oncology medication PAs and appeals, suggesting potential benefits for other…
Assessing the Impact of Patient Assistance Programs on Financial Toxicity in Oral Oncologyhttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-pr-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Shields explores the impact of the cost of oral oncology medications on clinical and economic outcomes in patients with cancer managed by HSSP clinical programs.
The Role of a Clinical Pharmacist in Melanoma Care and Educationhttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-news-round-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
It is estimated that 99,780 people in the United States will be diagnosed with melanoma in 2022. Because of the likelihood that patients with melanoma will develop adverse effects on therapy, it is crucial for pharmacists to proactively educate patients and provide them with tools to help mitigate and manage these issues. Read to learn more.
Oncologyhttps://shieldshealthsolutions.com/content/uploads/2021/11/Onc.png503503Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Cancer, a genetic disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body, is caused by changes to genes that control the…
Cancer patients, caregivers benefit with integrated clinic-to-pharmacy care through Prime Therapeutics’ IntegratedRx™ – Oncologyhttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-news-round.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Helping improve a member’s cancer care journey through coordinated care approach a cornerstone to putting the patient first, driving better quality, reducing drug costs, and improving medication adherence